Dissection of Cardiovascular Development and Disease Pathways in Zebrafish
Progress in Molecular Biology and Translational Science, ISSN: 1877-1173, Vol: 100, Page: 111-153
2011
- 10Citations
- 21Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations10
- Citation Indexes10
- 10
- CrossRef8
- Captures21
- Readers21
- 21
Book Chapter Description
The use of animal models in medicine has contributed significantly to the development of drug treatments and surgical procedures for the last century, in particular for cardiovascular disease. In order to model human disease in an animal, an appreciation of the strengths and limitations of the system are required to interpret results and design the logical sequence of steps toward clinical translation. As the world’s population ages, cardiovascular disease will become even more prominent and further progress will be essential to stave off what seems destined to become a massive public health issue. Future treatments will require the imaginative application of current models as well as the generation of new ones. In this review, we discuss the resources available for modeling cardiovascular disease in zebrafish and the varied attributes of this system. We then discuss current zebrafish disease models and their potential that has yet to be exploited.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/B9780123848789000042; http://dx.doi.org/10.1016/b978-0-12-384878-9.00004-2; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=79952420936&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/21377626; https://linkinghub.elsevier.com/retrieve/pii/B9780123848789000042; http://linkinghub.elsevier.com/retrieve/pii/B9780123848789000042; https://doi.org/10.1016%2Fb978-0-12-384878-9.00004-2; https://dx.doi.org/10.1016/b978-0-12-384878-9.00004-2
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know